SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review

Tao Yu,1,&ast; Hongquan Wang,2,&ast; Shuhan Zheng,1 Liang Huo1 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, People’s Republic of China; 2Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for C...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu T, Wang H, Zheng S, Huo L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	covid-19 cerebrovascular disease stroke cerebral hemorrhage cerebral venous thrombosis Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/8cc997d96d54452885edd14006e57165
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8cc997d96d54452885edd14006e57165
record_format	dspace
spelling	oai:doaj.org-article:8cc997d96d54452885edd14006e571652021-11-25T18:55:29ZSARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review1178-6973https://doaj.org/article/8cc997d96d54452885edd14006e571652021-11-01T00:00:00Zhttps://www.dovepress.com/sars-cov-2-associated-cerebrovascular-disease-amid-the-covid-19-pandem-peer-reviewed-fulltext-article-IDRhttps://doaj.org/toc/1178-6973Tao Yu,1,&ast; Hongquan Wang,2,&ast; Shuhan Zheng,1 Liang Huo1 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, People’s Republic of China; 2Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Liang HuoDepartment of Pediatrics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang, Liaoning, 110004, People’s Republic of ChinaEmail huol@sj-hospital.orgBackground: Cerebrovascular diseases associated with SARS-CoV-2 are being increasingly reported in the literature as the coronavirus disease 2019 (COVID-19) pandemic continues. However, a case-based retrospective analysis of the literature about SARS-CoV-2-cerebrovascular disease (SCVD) is not yet well established. Thus, we reviewed the literature on SCVD covering a comprehensive range of topics spanning the clinical features, mechanism, treatment, and outcomes of patients with SCVD.Methods: We searched PubMed® and included single-case reports and case series with full text in English that reported original data of patients with CVD and a confirmed recent SARS-CoV-2 infection. Clinical data were extracted.Results: We included all 51 articles indexed in PubMed® that were published between January 1, 2020, and June 20, 2020. The selected studies reported a total of 167 cerebrovascular events including ischemic stroke, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral venous thrombosis in patients with confirmed COVID-19. The detailed demographic and clinical characteristics of patients with CVD are summarized.Conclusion: This summary of patient characteristics may help clinicians better anticipate SCVD outcomes and complications in their COVID-19 patients.Keywords: COVID-19, cerebrovascular disease, stroke, cerebral hemorrhage, cerebral venous thrombosisYu TWang HZheng SHuo LDove Medical Pressarticlecovid-19cerebrovascular diseasestrokecerebral hemorrhagecerebral venous thrombosisInfectious and parasitic diseasesRC109-216ENInfection and Drug Resistance, Vol Volume 14, Pp 4967-4975 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 cerebrovascular disease stroke cerebral hemorrhage cerebral venous thrombosis Infectious and parasitic diseases RC109-216
spellingShingle	covid-19 cerebrovascular disease stroke cerebral hemorrhage cerebral venous thrombosis Infectious and parasitic diseases RC109-216 Yu T Wang H Zheng S Huo L SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
description	Tao Yu,1,&ast; Hongquan Wang,2,&ast; Shuhan Zheng,1 Liang Huo1 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, People’s Republic of China; 2Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Liang HuoDepartment of Pediatrics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang, Liaoning, 110004, People’s Republic of ChinaEmail huol@sj-hospital.orgBackground: Cerebrovascular diseases associated with SARS-CoV-2 are being increasingly reported in the literature as the coronavirus disease 2019 (COVID-19) pandemic continues. However, a case-based retrospective analysis of the literature about SARS-CoV-2-cerebrovascular disease (SCVD) is not yet well established. Thus, we reviewed the literature on SCVD covering a comprehensive range of topics spanning the clinical features, mechanism, treatment, and outcomes of patients with SCVD.Methods: We searched PubMed® and included single-case reports and case series with full text in English that reported original data of patients with CVD and a confirmed recent SARS-CoV-2 infection. Clinical data were extracted.Results: We included all 51 articles indexed in PubMed® that were published between January 1, 2020, and June 20, 2020. The selected studies reported a total of 167 cerebrovascular events including ischemic stroke, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral venous thrombosis in patients with confirmed COVID-19. The detailed demographic and clinical characteristics of patients with CVD are summarized.Conclusion: This summary of patient characteristics may help clinicians better anticipate SCVD outcomes and complications in their COVID-19 patients.Keywords: COVID-19, cerebrovascular disease, stroke, cerebral hemorrhage, cerebral venous thrombosis
format	article
author	Yu T Wang H Zheng S Huo L
author_facet	Yu T Wang H Zheng S Huo L
author_sort	Yu T
title	SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
title_short	SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
title_full	SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
title_fullStr	SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
title_full_unstemmed	SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review
title_sort	sars-cov-2-associated cerebrovascular disease amid the covid-19 pandemic: a systematic review
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/8cc997d96d54452885edd14006e57165
work_keys_str_mv	AT yut sarscov2associatedcerebrovasculardiseaseamidthecovid19pandemicasystematicreview AT wangh sarscov2associatedcerebrovasculardiseaseamidthecovid19pandemicasystematicreview AT zhengs sarscov2associatedcerebrovasculardiseaseamidthecovid19pandemicasystematicreview AT huol sarscov2associatedcerebrovasculardiseaseamidthecovid19pandemicasystematicreview
_version_	1718410538895015936

SARS-CoV-2-Associated Cerebrovascular Disease Amid the COVID-19 Pandemic: A Systematic Review

Ejemplares similares